Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Specific VLA-4 inhibitor designed at Biogen for cell adhesion-mediated pathologies

Jan. 3, 2000

FDA approves new treatment for respiratory failure in neonates

Dec. 30, 1999

Asthma symptoms improve significantly, steroid use decreases in patients on anti-IgE therapy

Dec. 28, 1999

Genentech and Inspire enter respiratory therapeutics collaboration

Dec. 27, 1999

Genome Therapeutics achieves milestone in asthma genomics alliance with Schering-Plough

Dec. 23, 1999

Positive preliminary results achieved in phase III anti-IgE asthma study

Dec. 21, 1999

Seretide MDI submitted for European marketing approval

Dec. 17, 1999

Dual NK1/NK2 antagonists from HMR useful for asthma and related disorders

Dec. 17, 1999

PathoGenesis's TOBI approved in the U.K.

Dec. 17, 1999

AstraZeneca files for new asthma combination product in Sweden

Dec. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...